The company usually posts poor financials for mid or long term investments.
The company has poor fundamentals for a short-term investment strategy.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 105.72 USD in weekly data.
The close medium term support offers good timing for purchasing the stock.
The group's activity appears highly profitable thanks to its outperforming net margins.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
Analysts covering this company mostly recommend stock overweighting or purchase.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.67 times its estimated earnings per share for the ongoing year.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.
The technical configuration over the long term remains negative on the weekly chart below the resistance level at 148.06 USD